| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/13/2007 | CN1980670A Quinolone-containing medicinal composition |
| 06/13/2007 | CN1980644A Compositions containing nicorandil, preparation method and use |
| 06/13/2007 | CN1978536A Novel material forming supramolecular structures, process and uses |
| 06/13/2007 | CN1978498A Temperature-sensistive chitosan/polyvinyl alcohol gel, and its preparing method |
| 06/13/2007 | CN1978492A Polycaprolactone-polyethylene glycol block copolymer, and its preparing method and use |
| 06/13/2007 | CN1977976A Method for treating nerve injury and vector construct for the same |
| 06/13/2007 | CN1977975A Inclusion puerarin/cyclodextrin composition and its preparing method |
| 06/13/2007 | CN1977974A Indulion cyclodextrin/hydroxy camptothecin medicinal composition and its preparing method |
| 06/13/2007 | CN1977973A Use of oligo chitosan and its derivative as anti HIV-1 polypeptide drug carrier |
| 06/13/2007 | CN1977972A Anti tumour drug oral colon targeting preparation and its preparing method |
| 06/13/2007 | CN1977969A Drug injection of recombinant human erythropoietin |
| 06/13/2007 | CN1977918A Venous preparation and its preparing method |
| 06/13/2007 | CN1977862A Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/13/2007 | CN1977855A Medicinal composition containing mangiferin and its preparing method |
| 06/13/2007 | CN1977844A Pioglitazone and glimepiride compound dropping pill preparation and its preparing method |
| 06/13/2007 | CN1977831A Inclusion cyclodextrin/vanillin ex polar bear medicinal composition and its preparing method |
| 06/13/2007 | CN1977826A Method for increasing prodrug bioavailability using solid lipid nano granule |
| 06/13/2007 | CN1977825A Aseptic medicinal composition |
| 06/13/2007 | CN1321111C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 06/13/2007 | CN1320928C Eye drops |
| 06/13/2007 | CN1320927C Cytomembrane imitated polymer micella as medicine carrying system |
| 06/13/2007 | CN1320926C Ginkgo leaf extract composition and its prepn |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/13/2007 | CN1320878C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230085 Anti-DOTA antibody |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230081 Interferon gamma conjugates |
| 06/12/2007 | US7230068 water-soluble compound that includes a polyether or vinyl ether with at least one terminal azide moiety; for linkage of water soluble polymers to a therapeutic agent |
| 06/12/2007 | US7230061 Process for production of water-soluble (meth)acrylic polymers, water-soluble (meth)acrylic polymers, and use thereof |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230014 For therapy of peptic ulcers with solution of an antiulcerative agent in isotonic solutions for intravenous administration, such as dextrose or sodium chloride, with high pH, and glycine-sodium hydroxide buffer; discoloration inhibition |
| 06/12/2007 | US7230005 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug |
| 06/12/2007 | US7229985 2-(1-isopropoxy-carbonyloxy-2-methylpropyl)-7, 8-dimethoxy-4(5H), 10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine having a solubility of 15-20 mu g/mL in a 1 wt % methylcellulose solution at 37 degrees and a polymer, especially methylcellulose and/or hydroxypropylmethylcellulose. |
| 06/12/2007 | US7229982 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; for treatment of atheroslerosis |
| 06/12/2007 | US7229977 Composition for soluble films with a new hydrolyzed polysaccharide |
| 06/12/2007 | US7229961 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 06/12/2007 | US7229959 Supplemented fibrin matrix delivery systems |
| 06/12/2007 | US7229841 Expression vector for use treatment of cancer |
| 06/12/2007 | US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 06/12/2007 | US7229645 Spray freeze-dried compositions |
| 06/12/2007 | US7229643 Solid oral formulation coated with hydroxypropyl methylcellulose; the polymer coating is free of polyethylene glycol |
| 06/12/2007 | US7229642 Amino acid modulated extended release dosage form |
| 06/12/2007 | US7229639 Antiinflammatory agents, analgesics, antiarthritic agents; liquid filled capsulaes |
| 06/12/2007 | US7229637 Food additives |
| 06/12/2007 | US7229630 Reverse of anesthetic |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229624 Ordered molecular presentation of antigens, method of preparation and use |
| 06/12/2007 | US7229621 Method to enhance the immunogenicity of an antigen |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | US7229490 Ready to use natural pigment dispersion (e.g., porphyrin pigment, carmine, curcumin or a carotenoid)of bodies of an average size of at most 10 mu m, dispersed without use of a surfactant in an an aqueous phase including a hydrocolloid; food coloring |
| 06/12/2007 | CA2316985C Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer |
| 06/12/2007 | CA2287257C 1,2,4-benzotriazine oxides formulations |
| 06/12/2007 | CA2246235C Colonic delivery of nicotine to treat inflammatory bowel disease |
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/09/2007 | CA2566267A1 Thymidylate kinase mutants and uses thereof |
| 06/07/2007 | WO2007065036A2 Therapeutic conjugates and methods of using same |
| 06/07/2007 | WO2007064762A2 Conjugates of amino acids and vitamin b3 for percutaneous delivery of vitamin b3 |
| 06/07/2007 | WO2007064345A2 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 06/07/2007 | WO2007064152A1 Injectable thermosensitive pluronic hydrogels coupled with bioactive materials for tissue regeneration and preparation mehtod thereof |
| 06/07/2007 | WO2007063255A1 Composition in the form of a spray containing a vitamin d derivative and an oil phase |
| 06/07/2007 | WO2007063254A1 Composition in the form of a spray containing a corticoid and an oil phase |
| 06/07/2007 | WO2007063124A1 Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma |
| 06/07/2007 | WO2007063043A1 Improved anti-microbial composition |
| 06/07/2007 | WO2007062610A2 Four branched dendrimer-peg for conjugation to proteins and peptides |
| 06/07/2007 | WO2007062564A1 Lyophilized taxane-liposome composition and its preparing process |
| 06/07/2007 | WO2007062462A1 Method for administering a skin necrosis composition to an animal |
| 06/07/2007 | WO2007044681A3 Reduction of saltiness with sweeteners |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007043702A9 Agent for applying to mucosa and method for production thereof |
| 06/07/2007 | WO2007041364A9 Conjugates for modulating the immune tolerance |
| 06/07/2007 | WO2007031753A3 Topical film-forming monophasic formulations |
| 06/07/2007 | WO2007031326A3 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 06/07/2007 | WO2007005421A3 Long lasting alginate dry eye, related methods of manufacture and methods of use |
| 06/07/2007 | WO2007002897A3 Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease |
| 06/07/2007 | WO2007002709A3 Complexation of metal ions with polypeptides |
| 06/07/2007 | WO2006138366A3 Protein markers |
| 06/07/2007 | WO2006122249A3 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions |
| 06/07/2007 | WO2006116789A3 Permeable capsules |
| 06/07/2007 | WO2006112777A3 Uses of rhcc in drug delivery, real filtering, chemical catalysis and production of nanoparticles |
| 06/07/2007 | WO2006106103A3 Prevention of hiv- infection with tmc278 |
| 06/07/2007 | WO2006099313A3 Phosphate conjugates of prenylation inhibitors |
| 06/07/2007 | WO2006086733A3 Process for preparing maytansinoid antibody conjugates |
| 06/07/2007 | WO2006082184A3 Conjugates of a polypeptide and a pentasaccharide |
| 06/07/2007 | WO2005115418A3 New hydroxapatite calcium phosphates, their method of preparation and their applications |
| 06/07/2007 | WO2005110418A3 Transdermal administration of phycotoxins |
| 06/07/2007 | WO2005104712A3 Dpi formulation containing sulfoalkyl ether cyclodextrin |
| 06/07/2007 | WO2005042584A3 Sulfoalkyl ether-alkyl ether cyclodextrin derivatives |
| 06/07/2007 | WO2005020918A3 Ultrasonic concentration of drug delivery capsules |
| 06/07/2007 | US20070129448 Compositions and methods of delivery of pharmacological agents |
| 06/07/2007 | US20070129328 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
| 06/07/2007 | US20070129287 Hemoglobin conjugates |
| 06/07/2007 | US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 06/07/2007 | US20070128680 Reacting a dicarboxylic acid with a water soluble hydrazine in the presence of a Lewis acid (NbCl5); forming phthalazinediones such as luminol |
| 06/07/2007 | US20070128575 Implantable devices for chemonucleolysis of intervertebral discs |
| 06/07/2007 | US20070128440 Cellular probes |
| 06/07/2007 | US20070128287 Dermal composition for external use |
| 06/07/2007 | US20070128276 Controlled release compositions comprising nimesulide |
| 06/07/2007 | US20070128273 Composition containing medicine extremely slightly soluble in water and method for preparation thereof |